Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges

The Direct Oral Anticoagulants (DOACs) represent a new generation of antithrombotic agents, providing direct inhibition of either thrombin (factor IIa; FIIa) or activated factor X (FXa). Around the globe, their use is progressively rising, as these new agents replace the historical anticoagulants (h...

Full description

Saved in:

Bibliographic Details
Published in:	Current drug metabolism Vol. 18; no. 7; p. 598
Main Authors:	Favaloro, Emmanuel J, Pasalic, Leonardo, Curnow, Jennifer, Lippi, Giuseppe
Format:	Journal Article
Language:	English
Published:	Netherlands 01.07.2017
Subjects:	Administration, Oral Anticoagulants - pharmacology Anticoagulants - therapeutic use Blood Coagulation Tests Drug Monitoring Humans Laboratories NOACs DOACs Non-vitamin K antagonist oral anticoagulants dabigatran Direct oral anticoagulants rivaroxaban monitoring apixaban edoxaban measurement betrixaban
ISSN:	1875-5453, 1875-5453
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!